{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:59:13Z","timestamp":1791928753363,"version":"4.3.4"},"reference-count":83,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"4","license":[{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2021,4,8]]},"DOI":"10.1167\/iovs.62.4.11","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T10:31:47Z","timestamp":1617877907000},"page":"11","source":"Crossref","is-referenced-by-count":15,"title":["Subretinal Rather Than Intravitreal Adeno-Associated Virus\u2013Mediated Delivery of a Complement Alternative Pathway Inhibitor Is Effective in a Mouse Model of RPE Damage"],"prefix":"10.1167","volume":"62","author":[{"given":"Balasubramaniam","family":"Annamalai","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Medical University of South Carolina, Charleston, South Carolina, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Parsons","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Medical University of South Carolina, Charleston, South Carolina, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"Nicholson","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Medical University of South Carolina, Charleston, South Carolina, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Obert","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Medical University of South Carolina, Charleston, South Carolina, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Utah, Salt Lake City, Utah, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e4rbel","family":"Rohrer","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Medical University of South Carolina, Charleston, South Carolina, United States"},{"name":"Division of Research, Ralph H. Johnson VA Medical Center, Charleston, South Carolina, United States"},{"name":"Department of Neurosciences, Medical University of South Carolina, Charleston, South Carolina, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/eye.2001.140","article-title":"Photoreceptor topography in ageing and age-related maculopathy","volume":"15","author":"Curcio","year":"2001","journal-title":"Eye"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.mam.2012.04.005","article-title":"Understanding age-related macular degeneration (AMD): relationships between the photoreceptor\/retinal pigment epithelium\/Bruch's membrane\/choriocapillaris complex","volume":"33","author":"Bhutto","year":"2012","journal-title":"Mol Aspects Med"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"7304","DOI":"10.1523\/JNEUROSCI.0190-15.2015","article-title":"Investigating mitochondria as a target for treating age-related macular degeneration","volume":"35","author":"Terluk","year":"2015","journal-title":"J Neurosci"},{"issue":"8","key":"bib5","doi-asserted-by":"publisher","first-page":"e126747","DOI":"10.1172\/jci.insight.126747","article-title":"Blood-retina barrier failure and vision loss in neuron-specific degeneration","volume":"4","author":"Ivanova","year":"2019","journal-title":"JCI Insight"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.mam.2012.03.007","article-title":"Complement dysregulation in AMD: RPE-Bruch's membrane-choroid","volume":"33","author":"Sparrow","year":"2012","journal-title":"Mol Aspects Med"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1006\/smim.1998.0137","article-title":"The complement system and adaptive immunity","volume":"10","author":"Fearon","year":"1998","journal-title":"Semin Immunol"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0162-3109(00)80298-2","article-title":"Phenotypes of complement knockouts","volume":"49","author":"Holers","year":"2000","journal-title":"Immunopharmacology"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev.bi.57.070188.001541","article-title":"Molecular organization and function of the complement system","volume":"57","author":"Muller-Eberhard","year":"1988","journal-title":"Annu Rev Biochem"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40246-016-0079-x","article-title":"AMD and the alternative complement pathway: genetics and functional implications","volume":"10","author":"Tan","year":"2016","journal-title":"Hum Genomics"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00281-017-0649-6","article-title":"The eye as a complement dysregulation hotspot","volume":"40","author":"Clark","year":"2018","journal-title":"Semin Immunopathol"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","article-title":"Overview of complement activation and regulation","volume":"33","author":"Noris","year":"2013","journal-title":"Semin Nephrol"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1479-7364-6-13","article-title":"Genetic mechanisms and age-related macular degeneration: common variants, rare variants, copy number variations, epigenetics, and mitochondrial genetics","volume":"6","author":"Liu","year":"2012","journal-title":"Hum Genomics"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.ophtha.2013.09.044","article-title":"Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the complete study","volume":"121","author":"Yehoshua","year":"2014","journal-title":"Ophthalmology"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4103\/0974-9233.173134","article-title":"Update on clinical trials in dry age-related macular degeneration","volume":"23","author":"Taskintuna","year":"2016","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"395","key":"bib16","doi-asserted-by":"publisher","first-page":"eaff1433","DOI":"10.1126\/scitranslmed.aaf1443","article-title":"Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration","volume":"9","author":"Yaspan","year":"2017","journal-title":"Sci Transl Med"},{"issue":"7","key":"bib17","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.oret.2020.01.019","article-title":"Visual function decline resulting from geographic atrophy: results from the Chroma and Spectri phase 3 trials","volume":"4","author":"Heier","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"108391","DOI":"10.1016\/j.clim.2020.108391","article-title":"Prolonged intraocular residence and retinal tissue distribution of a fourth-generation compstatin-based C3 inhibitor in non-human primates","volume":"214","author":"Hughes","year":"2020","journal-title":"Clin Immunol"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.3389\/fimmu.2017.01778","article-title":"Bruch's membrane compartmentalizes complement regulation in the eye with implications for therapeutic design in age-related macular degeneration","volume":"8","author":"Clark","year":"2017","journal-title":"Front Immunol"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.exer.2011.06.015","article-title":"Elevated membrane attack complex in human choroid with high risk complement factor H genotypes","volume":"93","author":"Mullins","year":"2011","journal-title":"Exp Eye Res"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1016\/j.ajpath.2014.07.017","article-title":"The membrane attack complex in aging human choriocapillaris: relationship to macular degeneration and choroidal thinning","volume":"184","author":"Mullins","year":"2014","journal-title":"Am J Pathol"},{"key":"bib22","first-page":"183","article-title":"The outer limiting membrane (OLM) revisited: clinical implications","volume":"4","author":"Omri","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1152\/physrev.00021.2004","article-title":"The retinal pigment epithelium in visual function","volume":"85","author":"Strauss","year":"2005","journal-title":"Physiol Rev"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/978-1-4614-4118-2","article-title":"CR2-mediated targeting of complement inhibitors: bench-to-bedside using a novel strategy for site-specific complement modulation","volume":"735","author":"Holers","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12974-015-0464-8","article-title":"Modulation of post-stroke degenerative and regenerative processes and subacute protection by site-targeted inhibition of the alternative pathway of complement","volume":"12","author":"Alawieh","year":"2015","journal-title":"J Neuroinflammation"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"16939","DOI":"10.1074\/jbc.M808166200","article-title":"Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury","volume":"284","author":"Thurman","year":"2009","journal-title":"J Biol Chem"},{"issue":"18","key":"bib27","doi-asserted-by":"publisher","first-page":"12753","DOI":"10.1074\/jbc.M112.421891","article-title":"Oxidative stress sensitizes RPE cells to complement-mediated injury in a natural antibody-, lectin pathway- and phospholipid epitope-dependent manner","volume":"288","author":"Joseph","year":"2013","journal-title":"J Biol Chem"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1073\/pnas.0408835103","article-title":"Drusen complement components C3a and C5a promote choroidal neovascularization","volume":"103","author":"Nozaki","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1167\/iovs.07-1194","article-title":"Effects of an anti-VEGF-A monoclonal antibody on laser-induced choroidal neovascularization in mice: optimizing methods to quantify vascular changes","volume":"49","author":"Campa","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"e67894","DOI":"10.1371\/journal.pone.0067894","article-title":"Alternative complement pathway deficiency ameliorates chronic smoke-induced functional and morphological ocular injury","volume":"8","author":"Woodell","year":"2013","journal-title":"PLoS ONE"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1167\/iovs.08-2222","article-title":"A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration","volume":"50","author":"Rohrer","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1167\/iovs.15-18471","article-title":"A targeted inhibitor of the alternative complement pathway accelerates recovery from smoke-induced ocular injury","volume":"57","author":"Woodell","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/tvst.7.2.3","article-title":"Encapsulated cell technology-based delivery of a complement inhibitor reduces choroidal neovascularization in a mouse model","volume":"7","author":"Annamalai","year":"2018","journal-title":"Transl Vis Sci Technol"},{"key":"bib34","first-page":"370","article-title":"The use of Matrigel combined with encapsulated cell technology to deliver a complement inhibitor in a mouse model of choroidal neovascularization","volume":"26","author":"Annamalai","year":"2020","journal-title":"Mol Vision"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtm.2017.11.003","article-title":"Delivery of CR2-fH using AAV vector therapy as treatment strategy in the mouse model of choroidal neovascularization","volume":"9","author":"Schnabolk","year":"2018","journal-title":"Mol Ther Methods Clin Dev"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1172\/JCI17348","article-title":"Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation","volume":"111","author":"Song","year":"2003","journal-title":"J Clin Invest"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/gt.2013.64","article-title":"Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach","volume":"21","author":"Mowat","year":"2014","journal-title":"Gene Ther"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1089\/hum.2005.16.649","article-title":"Adeno-associated virus-vectored gene therapy for retinal disease","volume":"16","author":"Dinculescu","year":"2005","journal-title":"Hum Gene Ther"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1093\/hmg\/10.26.3075","article-title":"Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model","volume":"10","author":"Auricchio","year":"2001","journal-title":"Hum Mol Genet"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.visres.2007.08.009","article-title":"Comparative analysis of in vivo and in vitro AAV vector transduction in the neonatal mouse retina: effects of serotype and site of administration","volume":"48","author":"Pang","year":"2008","journal-title":"Vision Res"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1167\/iovs.61.3.45","article-title":"Immunization against oxidized elastin exacerbates structural and functional damage in mouse model of smoke-induced ocular injury","volume":"61","author":"Annamalai","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"e1000074","DOI":"10.1371\/journal.pbio.1000074","article-title":"A computational framework for ultrastructural mapping of neural circuitry","volume":"7","author":"Anderson","year":"2009","journal-title":"PLoS Biol"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jneumeth.2010.10.008","article-title":"Culturing conditions determine neuronal and glial excitability","volume":"194","author":"Stoppelkamp","year":"2010","journal-title":"J Neurosci Methods"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.bbamcr.2014.11.002","article-title":"Quantitative analysis of mitochondrial morphology and membrane potential in living cells using high-content imaging, machine learning, and morphological binning","volume":"1853","author":"Leonard","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1172\/JCI65861","article-title":"Detection of complement activation using monoclonal antibodies against C3d","volume":"123","author":"Thurman","year":"2013","journal-title":"J Clin Invest"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"16939","DOI":"10.1074\/jbc.M808166200","article-title":"Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury","volume":"284","author":"Thurman","year":"2009","journal-title":"J Biol Chem"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.exer.2007.08.010","article-title":"VEGF modulation of retinal pigment epithelium resistance","volume":"85","author":"Ablonczy","year":"2007","journal-title":"Exp Eye Res"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/cdd.2015.164","article-title":"Factor H uptake regulates intracellular C3 activation during apoptosis and decreases the inflammatory potential of nucleosomes","volume":"23","author":"Martin","year":"2016","journal-title":"Cell Death Differ"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"14534","DOI":"10.1074\/jbc.M114.564674","article-title":"Smoke exposure causes endoplasmic reticulum stress and lipid accumulation in retinal pigment epithelium through oxidative stress and complement activation","volume":"289","author":"Kunchithapautham","year":"2014","journal-title":"J Biol Chem"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"e1985","DOI":"10.1038\/cddis.2015.333","article-title":"Blue light-induced retinal lesions, intraretinal vascular leakage and edema formation in the all-cone mouse retina","volume":"6","author":"Geiger","year":"2015","journal-title":"Cell Death Dis"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jama.296.3.301","article-title":"Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration","volume":"296","author":"Despriet","year":"2006","journal-title":"JAMA"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.preteyeres.2009.11.003","article-title":"The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited","volume":"29","author":"Anderson","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/14712598.2019.1575358","article-title":"Complement inhibition as a therapeutic strategy in retinal disorders","volume":"19","author":"Kassa","year":"2019","journal-title":"Expert Opin Biol Ther"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S1350-9462(01)00010-6","article-title":"An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration","volume":"20","author":"Hageman","year":"2001","journal-title":"Prog Retin Eye Res"},{"key":"bib55","first-page":"357","article-title":"Immunohistochemical localization of complement regulatory proteins in the human retina","volume":"27","author":"Fett","year":"2012","journal-title":"Histol Histopathol"},{"key":"bib56","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.exer.2011.06.002","article-title":"Retinal pigment epithelial expression of complement regulator CD46 is altered early in the course of geographic atrophy","volume":"93","author":"Vogt","year":"2011","journal-title":"Exp Eye Res"},{"key":"bib57","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/path.4128","article-title":"Decreased membrane complement regulators in the retinal pigmented epithelium contributes to age-related macular degeneration","volume":"229","author":"Ebrahimi","year":"2013","journal-title":"J Pathol"},{"key":"bib58","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1167\/iovs.08-3202","article-title":"Expression and modulation of RPE cell membrane complement regulatory proteins","volume":"50","author":"Yang","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1002\/sct3.v9.12","article-title":"Complement modulation reverses pathology in Y402H-retinal pigment epithelium cell model of age-related macular degeneration by restoring lysosomal function","volume":"9","author":"Cerniauskas","year":"2020","journal-title":"Stem Cells Transl Med"},{"key":"bib60","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1167\/iovs.61.3.18","article-title":"Complement activation levels are related to disease stage in AMD","volume":"61","author":"Heesterbeek","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib61","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.molimm.2019.02.001","article-title":"Inhibition of the alternative complement pathway accelerates repair processes in the murine model of choroidal neovascularization","volume":"108","author":"Parsons","year":"2019","journal-title":"Mol Immunol"},{"issue":"8","key":"bib62","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.ophtha.2013.01.004","article-title":"Age-related macular degeneration and modification of systemic complement factor H production through liver transplantation","volume":"120","author":"Khandhadia","year":"2013","journal-title":"Ophthalmology"},{"key":"bib63","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1167\/iovs.14-15910","article-title":"Local production of the alternative pathway component factor B is sufficient to promote laser-induced choroidal neovascularization","volume":"56","author":"Schnabolk","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib64","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1172\/JCI89412","article-title":"A C3(H20) recycling pathway is a component of the intracellular complement system","volume":"127","author":"Elvington","year":"2017","journal-title":"J Clin Invest"},{"key":"bib65","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/eji.v46.7","article-title":"A novel \u201ccomplement-metabolism-inflammasome axis\u201d as a key regulator of immune cell effector function","volume":"46","author":"Arbore","year":"2016","journal-title":"Eur J Immunol"},{"key":"bib66","doi-asserted-by":"publisher","first-page":"10320","DOI":"10.1038\/s41598-020-67292-z","article-title":"Loss of complement factor H impairs antioxidant capacity and energy metabolism of human RPE cells","volume":"10","author":"Armento","year":"2020","journal-title":"Sci Rep"},{"key":"bib67","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/imr.12470","article-title":"Injury site-specific targeting of complement inhibitors for treating stroke","volume":"274","author":"Alawieh","year":"2016","journal-title":"Immunol Rev"},{"key":"bib68","doi-asserted-by":"publisher","first-page":"8068","DOI":"10.4049\/jimmunol.181.11.8068","article-title":"A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia\/reperfusion injury","volume":"181","author":"Huang","year":"2008","journal-title":"J Immunol"},{"key":"bib69","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1080\/13816810.2018.1533027","article-title":"Gene therapy for RPE65-related retinal disease","volume":"39","author":"MiraldiUtz","year":"2018","journal-title":"Ophthalmic Genet"},{"key":"bib70","first-page":"2295","article-title":"GT005, a gene therapy for the treatment of dry age-related macular degeneration (AMD)","volume":"61","author":"Ellis","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10089","key":"bib71","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S0140-6736(17)30979-0","article-title":"Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial","volume":"390","author":"Heier","year":"2017","journal-title":"Lancet"},{"key":"bib72","first-page":"16","article-title":"Clinical trial download: data on a gene therapy for dry and wet AMD","volume":"17","author":"Dugel","year":"2020","journal-title":"Retinal Physician"},{"key":"bib73","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1177\/019262339902700507","article-title":"Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labeled full-length and Fab antibodies in rhesus monkeys following intravitreal administration","volume":"27","author":"Mordenti","year":"1999","journal-title":"Toxicol Pathol"},{"key":"bib74","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/978-3-319-75402-4","article-title":"Opposite roles of MerTK ligands Gas6 and protein S during retinal phagocytosis","volume":"1074","author":"Nandrot","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"bib75","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1016\/j.bbadis.2018.04.016","article-title":"Extracellular vesicle-mediated long-range communication in stressed retinal pigment epithelial cell monolayers","volume":"1864","author":"Shah","year":"2018","journal-title":"Biochim Biophys Acta"},{"key":"bib76","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1034\/j.1600-0773.2002.910305.x","article-title":"Glutamate uptake is inhibited by tamoxifen and toremifene in cultured retinal pigment epithelial cells","volume":"91","author":"Maenpaa","year":"2002","journal-title":"Pharmacol Toxicol"},{"key":"bib77","doi-asserted-by":"publisher","first-page":"9014","DOI":"10.1073\/pnas.1805039115","article-title":"Aberrant early endosome biogenesis mediates complement activation in the retinal pigment epithelium in models of macular degeneration","volume":"115","author":"Kaur","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib78","doi-asserted-by":"publisher","first-page":"15440","DOI":"10.1038\/s41598-019-51777-7","article-title":"Proteome and secretome dynamics of human retinal pigment epithelium in response to reactive oxygen species","volume":"9","author":"Meyer","year":"2019","journal-title":"Sci Rep"},{"key":"bib79","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000090268","article-title":"Inhibition of lysosomal degradation in retinal pigment epithelium cells induces exocytosis of phagocytic residual material at the basolateral plasma membrane","volume":"38","author":"Peters","year":"2006","journal-title":"Ophthalmic Res"},{"key":"bib80","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1097\/IAE.0b013e3181f57e30","article-title":"Pathway-based therapies for age-related macular degeneration: an integrated survey of emerging treatment alternatives","volume":"30","author":"Zarbin","year":"2010","journal-title":"Retina"},{"key":"bib81","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1172\/JCI111760","article-title":"Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement","volume":"75","author":"Kew","year":"1985","journal-title":"J Clin Invest"},{"key":"bib82","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/gt.2015.96","article-title":"Photoreceptor-targeted gene delivery using intravitreally administered AAV vectors in dogs","volume":"23","author":"Boyd","year":"2016","journal-title":"Gene Ther"},{"key":"bib83","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.omtm.2018.12.006","article-title":"Trans-ocular electric current in vivo enhances AAV-mediated retinal gene transduction after intravitreal vector administration","volume":"13","author":"Song","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"key":"bib2","first-page":"465","volume-title":"Structure, Function, and Pathology of Bruch's Membrane","author":"Curcio","year":"2013"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2772461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:23Z","timestamp":1791927083000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2772461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,8]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.62.4.11","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,8]]}}}